Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Ikarian Capital, LLC
Form 13F · Q2 2026

Ikarian Capital, LLC

CIK 1778253申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$9.3亿
申报组合市值
156
持仓数量
12
Quarters on record
Top 50
持仓数量

Ikarian Capital, LLC——持仓

共 156 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ABVX Abivax Sa328,635+470.2%$4335万4.7%
2KOD Kodiak Sciences Inc1.1M−16.3%$4129万4.4%
3ALMS Alumis Inc870,548−28.3%$2450万2.6%
4PRAX Praxis Precision Medicines I72,842+1.8%$2439万2.6%
5PCVX Vaxcyte Inc388,682−9.3%$2259万2.4%
6ANIP Ani Pharmaceuticals Inc272,085+85.0%$2252万2.4%
7CLDX Celldex Therapeutics Inc New478,500+3.7%$1780万1.9%
8RCUS Arcus Biosciences Inc504,559—$1556万1.7%
9RLMD Relmada Therapeutics Inc2.1M−20.1%$1487万1.6%
10CAPR Capricor Therapeutics Inc604,215+14.4%$1455万1.6%
11COGT Cogent Biosciences Inc370,084—$1432万1.5%
12VERA Vera Therapeutics Inc310,000+55.0%$1330万1.4%
13CTNM Contineum Therapeutics Inc807,874+0.0%$1324万1.4%
14TENX Tenax Therapeutics Inc787,600−22.6%$1146万1.2%
15CCCC C4 Therapeutics Inc2.4M—$1136万1.2%
16MAZE Maze Therapeutics Inc378,999+0.0%$1131万1.2%
17BHVN Biohaven Ltd748,181+81.4%$1113万1.2%
18CNTB Connect Biopharma Hldgs Ltd4.5M−15.8%$1080万1.2%
19ANRO Alto Neuroscience Inc407,338−20.9%$1075万1.2%
20PHVS Pharvaris N V308,856−36.6%$1068万1.2%
21JBIO Jade Biosciences Inc427,349−16.6%$950万1.0%
22DMRA Damora Therapeutics Inc335,710+0.0%$873万0.9%
23VRDN Viridian Therapeutics Inc425,000—$781万0.8%
24PTHS Pelthos Therapeutics Inc256,598+0.0%$725万0.8%
25ZURA Zura Bio Ltd1.2M+2.1%$719万0.8%
26TECX Tectonic Therapeutic Inc205,837+30.7%$708万0.8%
27SPRB Spruce Biosciences Inc121,356+0.0%$655万0.7%
28HIMS Hims & Hers Health Inc188,381—$653万0.7%
29ELVN Enliven Therapeutics Inc126,541—$642万0.7%
30PRQR Proqr Thrapeutics N V3.4M+129.6%$637万0.7%
31DRUG Bright Minds Biosciences Inc88,951−46.6%$624万0.7%
32OVID Ovid Therapeutics Inc2.3M−21.6%$611万0.7%
33OCGN Ocugen Inc4.0M+0.0%$606万0.7%
34ACOG Alpha Cognition Inc836,259−20.8%$604万0.7%
35HROW Harrow Inc135,775−75.0%$577万0.6%
36KZIA Kazia Therapeutics Ltd396,201—$558万0.6%
37RARE Ultragenyx Pharmaceutical In165,617−65.7%$553万0.6%
38QTTB Q32 Bio Inc430,000—$548万0.6%
39EPRX Eupraxia Pharmaceuticals Inc809,741−33.3%$535万0.6%
40BIOA Bioage Labs Inc200,000—$490万0.5%
41RZLT Rezolute Inc935,012+5574.0%$486万0.5%
42OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc383,281−35.9%$479万0.5%
43MNPR Monopar Therapeutics Inc47,861—$443万0.5%
44BBIO Bridgebio Pharma Inc57,417−64.1%$428万0.5%
45IVA Inventiva Sa1.1M−21.0%$415万0.4%
46ABSI Absci Corporation353,772—$410万0.4%
47ALEC Alector Inc2.0M−4.8%$399万0.4%
48CLYM Climb Bio Inc300,000—$391万0.4%
49FULC Fulcrum Therapeutics Inc1.0M+0.0%$384万0.4%
50CRDL Cardiol Therapeutics Inc3.3M+22.0%$352万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。